LUNG on XNAS, Health Care, Pulmonx Corporation, job postings
Measures activity, not value. Not investment advice.
Shares rose 96% in a year while quarterly revenue grew 6.2% to $22.8M.
BadTwelve-month revenue fell 3.2% to $88.8M
BadNet loss of $42.6M over twelve months, free cash flow -$25.6M
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.
Industry
Surgical & medical instruments & apparatus (Health Care)
expected around 3 Mar 2027 (an estimate: a year ago it reported on 4 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $22.8M, net loss $8.4M.
31 Dec 2021RevenueNet incomeNet losstallest bar $23.9M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$22.8M
-$8.4M
30 Jun 2026
$22.8M
-$10.1M
31 Mar 2026
$20.6M
-$13.7M
31 Dec 2025
$22.6M
-$10.4M
30 Sep 2025
$21.5M
-$14.0M
30 Jun 2025
$23.9M
-$15.2M
31 Mar 2025
$22.5M
-$14.4M
31 Dec 2024
$23.8M
-$13.2M
30 Sep 2024
$20.4M
-$14.1M
30 Jun 2024
$20.8M
-$15.3M
31 Mar 2024
$18.9M
-$13.7M
31 Dec 2023
$19.3M
-$13.9M
30 Sep 2023
$17.7M
-$14.9M
30 Jun 2023
$17.2M
-$16.2M
31 Mar 2023
$14.5M
-$15.9M
31 Dec 2022
$15.4M
-$14.3M
30 Sep 2022
$13.5M
-$14.2M
30 Jun 2022
$13.9M
-$14.6M
31 Mar 2022
$10.8M
-$15.8M
31 Dec 2021
$13.7M
-$13.0M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$88.8M
$91.7M
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
-3.2%
+13%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
-$42.6M
-$56.8M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
-$1.01
-$1.41
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
77.4%
73.3%
60.5%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
-44.4%
-62.4%
-8.3%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
-47.9%
-61.9%
-10.1%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
-90.3%
-26.3%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
-$25.6M
-$32.6M
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$52.7M
$76.5M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$37.9M
$37.2M
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
-$14.8M (net cash)
-$39.3M
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
1.1
0.31
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$0.79
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
loss
28.0
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
1.3
2.3
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
1.1
2.5
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
3.3
2.8
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
-$177K
bought $0, sold $177K
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
-4.8%
100 13F filers vs 105
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
59%
25.5M shares held by 13F filers (30 Sep 2026) of 43.6M outstanding (29 Oct 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
1.8%
788K shares sold short (30 Oct 2026) of 43.6M outstanding (29 Oct 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
1.0
788K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
+13%
699K shares sold short in the report before, 788K on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
32%
32% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 44%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
–
We do not track this company's careers site yet.
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
We do not track this company's careers site yet.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
–
No data for this company
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+6.2%
$22.8M vs $21.5M (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
–
No data for this company
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
$106K
the 12 months before: $455K
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
–
No data for this company
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
7
7 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
–
7 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.
Price $2.57 on 20 Nov 2026, +96% over 12 months (12-month range $1.17 to $3.17)
Sharp change
8-K and other filings
Insider net buying (open market). Insiders sold a net $548K in the last 12 months (the 12 months before: -$1.3M).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 0 published in the last 12 months.Revenue per quarter. Revenue $22.8M in the latest quarter, +6.2% on a year earlier.Capital spending per quarter. Capital spending $8K in the latest quarter, -91% on a year earlier.Institutional holders (13F filers). 100 13F filers reported holding it in the latest 13F quarter, +1.0% on a year earlier.Federal obligations. Federal obligations: $32K published in the last 12 months, -90% on the 12 months before.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: lobbying spend, workers in warn layoff notices.
Quarter ended 31 Dec 2021: $13.7M, +39% on a year earlier; public on 2 Mar 2022
Quarter ended 31 Mar 2022: $10.8M, +17% on a year earlier; public on 10 May 2022
Quarter ended 30 Jun 2022: $13.9M, +14% on a year earlier; public on 9 Aug 2022
Quarter ended 30 Sep 2022: $13.5M, +1.8% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $15.4M, +13% on a year earlier; public on 2 Mar 2023
Quarter ended 31 Mar 2023: $14.5M, +35% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $17.2M, +23% on a year earlier; public on 5 Aug 2023
Quarter ended 30 Sep 2023: $17.7M, +31% on a year earlier; public on 4 Nov 2023
Quarter ended 31 Dec 2023: $19.3M, +25% on a year earlier; public on 28 Feb 2024
Quarter ended 31 Mar 2024: $18.9M, +30% on a year earlier; public on 4 May 2024
Quarter ended 30 Jun 2024: $20.8M, +21% on a year earlier; public on 3 Aug 2024
Quarter ended 30 Sep 2024: $20.4M, +15% on a year earlier; public on 2 Nov 2024
Quarter ended 31 Dec 2024: $23.8M, +23% on a year earlier; public on 26 Feb 2025
Quarter ended 31 Mar 2025: $22.5M, +20% on a year earlier; public on 3 May 2025
Quarter ended 30 Jun 2025: $23.9M, +15% on a year earlier; public on 2 Aug 2025
Quarter ended 30 Sep 2025: $21.5M, +5.5% on a year earlier; public on 13 Nov 2025
Quarter ended 31 Dec 2025: $22.6M, -4.9% on a year earlier; public on 11 Mar 2026
Quarter ended 31 Mar 2026: $20.6M, -8.7% on a year earlier; public on 5 May 2026
Quarter ended 30 Jun 2026: $22.8M, -4.6% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $22.8M, +6.2% on a year earlier; public on 4 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $1.1M; public on 2 Mar 2022
Quarter ended 31 Mar 2022: $564K, +133% on a year earlier; public on 10 May 2022
Quarter ended 30 Jun 2022: $299K, -55% on a year earlier; public on 9 Aug 2022
Quarter ended 30 Sep 2022: $279K, -83% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $176K, -85% on a year earlier; public on 2 Mar 2023
Quarter ended 31 Mar 2023: $61K, -89% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $54K, -82% on a year earlier; public on 5 Aug 2023
Quarter ended 31 Dec 2023: $200K, +14% on a year earlier; public on 28 Feb 2024
Quarter ended 31 Mar 2024: $451K, +639% on a year earlier; public on 4 May 2024
Quarter ended 30 Jun 2024: $469K, +769% on a year earlier; public on 3 Aug 2024
Quarter ended 30 Sep 2024: $416K; public on 2 Nov 2024
Quarter ended 31 Dec 2024: $111K, -44% on a year earlier; public on 26 Feb 2025
Quarter ended 31 Mar 2025: $301K, -33% on a year earlier; public on 3 May 2025
Quarter ended 30 Jun 2025: $49K, -90% on a year earlier; public on 2 Aug 2025
Quarter ended 30 Sep 2025: $89K, -79% on a year earlier; public on 13 Nov 2025
Quarter ended 31 Dec 2025: $13K, -88% on a year earlier; public on 11 Mar 2026
Quarter ended 31 Mar 2026: $9K, -97% on a year earlier; public on 5 May 2026
Quarter ended 30 Jun 2026: $1K, -98% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $8K, -91% on a year earlier; public on 4 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 103; public on 14 Feb 2022
31 Mar 2022 report: 104; public on 16 May 2022
30 Jun 2022 report: 101; public on 15 Aug 2022
30 Sep 2022 report: 98; public on 14 Nov 2022
31 Dec 2022 report: 108; public on 14 Feb 2023
31 Mar 2023 report: 97; public on 15 May 2023
30 Jun 2023 report: 107; public on 14 Aug 2023
30 Sep 2023 report: 108; public on 14 Nov 2023
31 Dec 2023 report: 117; public on 14 Feb 2024
31 Mar 2024 report: 115; public on 15 May 2024
30 Jun 2024 report: 102; public on 14 Aug 2024
30 Sep 2024 report: 109; public on 14 Nov 2024
31 Dec 2024 report: 118; public on 14 Feb 2025
31 Mar 2025 report: 113; public on 15 May 2025
30 Jun 2025 report: 111; public on 14 Aug 2025
30 Sep 2025 report: 99; public on 14 Nov 2025
31 Dec 2025 report: 107; public on 17 Feb 2026
31 Mar 2026 report: 110; public on 15 May 2026
30 Jun 2026 report: 105; public on 14 Aug 2026
30 Sep 2026 report: 100; public on 16 Nov 2026
Federal obligations
Month from 1 Dec 2021: $34K published
Month from 1 Mar 2022: $11K published
Month from 1 Apr 2022: $29K published
Month from 1 Jul 2022: $11K published
Month from 1 Aug 2022: $43K published
Month from 1 Sep 2022: $45K published
Month from 1 Oct 2022: $11K published
Month from 1 Nov 2022: $167K published
Month from 1 Jan 2023: $25K published
Month from 1 Feb 2023: $12K published
Month from 1 Apr 2023: $15K published
Month from 1 May 2023: $66K published
Month from 1 Jun 2023: $19K published
Month from 1 Jul 2023: $44K published
Month from 1 Aug 2023: $65K published
Month from 1 Sep 2023: $98K published
Month from 1 Oct 2023: $56K published
Month from 1 Nov 2023: $27K published
Month from 1 Dec 2023: $28K published
Month from 1 Feb 2024: $34K published
Month from 1 Mar 2024: -$34.7 published
Month from 1 May 2024: $44K published
Month from 1 Jun 2024: $36K published
Month from 1 Jul 2024: $46K published
Month from 1 Aug 2024: $103K published
Month from 1 Sep 2024: $37K published
Month from 1 Oct 2024: $86K published
Month from 1 Nov 2024: $22K published
Month from 1 Dec 2024: $53K published
Month from 1 Jan 2025: $15K published
Month from 1 Feb 2025: $12K published
Month from 1 Mar 2025: $93K published
Month from 1 Apr 2025: $12K published
Month from 1 May 2025: $96.1 published
Month from 1 Jun 2025: $34K published
Month from 1 Jul 2025: $12K published
Month from 1 Aug 2025: $27K published
Month from 1 Sep 2025: $10K published
Month from 1 Oct 2025: $20K published
Month from 1 Nov 2025: $19K published
Month from 1 Jul 2026: $29K published
Month from 1 Oct 2026: $3K published
What is unusual now
Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $177K (3 Sep 2026), 2.1× its normal reading; higher than 60% of its own history.
Changes and notable records, by the date each became public
25 Mar 2026Short interest and volume change
had 3.3M shares sold short in the 13 Mar 2026 report, 2.8× the same report last year.
Same report last year: 1.2M; its normal report is 1.5M.
See the evidence
This period
3.3M (the 13 Mar 2026 report)
Normal report (median of 24 earlier)
1.5M
Typical spread (median absolute deviation)
333K
How far from its usual level
+3.5
Same report last year
1.2M
History used
1,975 days
the 13 Mar 2026 report24 earlier reportsnormal: 1.5M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 3.3M shares sold short in the 27 Feb 2026 report, 2.6× the same report last year.
Same report last year: 1.3M; its normal report is 1.5M.
See the evidence
This period
3.3M (the 27 Feb 2026 report)
Normal report (median of 24 earlier)
1.5M
Typical spread (median absolute deviation)
273K
How far from its usual level
+4.5
Same report last year
1.3M
History used
1,961 days
the 27 Feb 2026 report24 earlier reportsnormal: 1.5M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 3.3M shares sold short in the 13 Feb 2026 report, 2.9× the same report last year.
Same report last year: 1.1M; its normal report is 1.4M.
See the evidence
This period
3.3M (the 13 Feb 2026 report)
Normal report (median of 24 earlier)
1.4M
Typical spread (median absolute deviation)
226K
How far from its usual level
+5.5
Same report last year
1.1M
History used
1,947 days
the 13 Feb 2026 report24 earlier reportsnormal: 1.4M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 2.8M shares sold short in the 30 Jan 2026 report, 2.3× the same report last year.
Same report last year: 1.2M; its normal report is 1.4M.
See the evidence
This period
2.8M (the 30 Jan 2026 report)
Normal report (median of 24 earlier)
1.4M
Typical spread (median absolute deviation)
213K
How far from its usual level
+4.4
Same report last year
1.2M
History used
1,933 days
the 30 Jan 2026 report24 earlier reportsnormal: 1.4M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 2.6M shares sold short in the 15 Jan 2026 report, 2.1× the same report last year.
Same report last year: 1.3M; its normal report is 1.4M.
See the evidence
This period
2.6M (the 15 Jan 2026 report)
Normal report (median of 24 earlier)
1.4M
Typical spread (median absolute deviation)
191K
How far from its usual level
+4.3
Same report last year
1.3M
History used
1,918 days
the 15 Jan 2026 report24 earlier reportsnormal: 1.4M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 3.0M shares sold short in the 31 Dec 2025 report, 3.4× the same report last year.
Same report last year: 879K; its normal report is 1.4M.
See the evidence
This period
3.0M (the 31 Dec 2025 report)
Normal report (median of 24 earlier)
1.4M
Typical spread (median absolute deviation)
169K
How far from its usual level
+6.3
Same report last year
879K
History used
1,903 days
the 31 Dec 2025 report24 earlier reportsnormal: 1.4M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 3.1M shares sold short in the 15 Dec 2025 report, 3.7× the same report last year.
Same report last year: 832K; its normal report is 1.4M.
See the evidence
This period
3.1M (the 15 Dec 2025 report)
Normal report (median of 24 earlier)
1.4M
Typical spread (median absolute deviation)
169K
How far from its usual level
+6.9
Same report last year
832K
History used
1,887 days
the 15 Dec 2025 report24 earlier reportsnormal: 1.4M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 2.5M shares sold short in the 28 Nov 2025 report, 3.1× the same report last year.
Same report last year: 816K; its normal report is 1.3M.
See the evidence
This period
2.5M (the 28 Nov 2025 report)
Normal report (median of 24 earlier)
1.3M
Typical spread (median absolute deviation)
145K
How far from its usual level
+5.6
Same report last year
816K
History used
1,870 days
the 28 Nov 2025 report24 earlier reportsnormal: 1.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 2.0M shares sold short in the 14 Nov 2025 report, 2.4× the same report last year.
Same report last year: 843K; its normal report is 1.3M.
See the evidence
This period
2.0M (the 14 Nov 2025 report)
Normal report (median of 24 earlier)
1.3M
Typical spread (median absolute deviation)
135K
How far from its usual level
+3.8
Same report last year
843K
History used
1,856 days
the 14 Nov 2025 report24 earlier reportsnormal: 1.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 2.4M shares sold short in the 31 Oct 2025 report, 2.4× the same report last year.
Same report last year: 986K; its normal report is 1.3M.
See the evidence
This period
2.4M (the 31 Oct 2025 report)
Normal report (median of 24 earlier)
1.3M
Typical spread (median absolute deviation)
165K
How far from its usual level
+4.5
Same report last year
986K
History used
1,842 days
the 31 Oct 2025 report24 earlier reportsnormal: 1.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 2.8M shares sold short in the 15 Mar 2022 report, 2.4× the same report last year.
Same report last year: 1.1M; its normal report is 1.3M.
See the evidence
This period
2.8M (the 15 Mar 2022 report)
Normal report (median of 24 earlier)
1.3M
Typical spread (median absolute deviation)
288K
How far from its usual level
+3.6
Same report last year
1.1M
History used
516 days
the 15 Mar 2022 report24 earlier reportsnormal: 1.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 2.9M shares sold short in the 28 Feb 2022 report, 3.0× the same report last year.
Same report last year: 969K; its normal report is 1.2M.
See the evidence
This period
2.9M (the 28 Feb 2022 report)
Normal report (median of 24 earlier)
1.2M
Typical spread (median absolute deviation)
247K
How far from its usual level
+4.7
Same report last year
969K
History used
501 days
the 28 Feb 2022 report24 earlier reportsnormal: 1.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 2.6M shares sold short in the 15 Feb 2022 report, 2.8× the same report last year.
Same report last year: 922K; its normal report is 1.2M.
See the evidence
This period
2.6M (the 15 Feb 2022 report)
Normal report (median of 24 earlier)
1.2M
Typical spread (median absolute deviation)
241K
How far from its usual level
+3.9
Same report last year
922K
History used
488 days
the 15 Feb 2022 report24 earlier reportsnormal: 1.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 2.4M shares sold short in the 31 Jan 2022 report, 1.8× the same report last year.
Same report last year: 1.4M; its normal report is 1.2M.
See the evidence
This period
2.4M (the 31 Jan 2022 report)
Normal report (median of 24 earlier)
1.2M
Typical spread (median absolute deviation)
237K
How far from its usual level
+3.5
Same report last year
1.4M
History used
473 days
the 31 Jan 2022 report24 earlier reportsnormal: 1.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
Showing the newest 40 of 44 entries; narrow the window or the kind of data to see older ones.
Not listed: 190 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001127537
Ticker
LUNG
Domain
pulmonx.com
Employer name
Pulmonx, Inc (1 unverified)
Hq location
CA|REDWOOD CITY|94063 (1 unverified)
Name
Pulmonx Corporation
Uei
FNLDP73STNA9
DOL H-1B labor condition applications and PERM certifications26 data points28 Oct 2019 to 8 Apr 2024
SEC Form 13F institutional holdings216 data points31 Dec 2020 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)71 records3 Apr 2017 to 3 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)575 data points31 Dec 2017 to 29 Oct 2026
SEC Form 4 insider transactions143 records, 312 data points5 Oct 2020 to 3 Sep 2026
FINRA short interest (twice monthly)434 data points15 Oct 2020 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)3086 data points1 Oct 2020 to 20 Nov 2026
USASpending.gov federal awards285 data points9 Sep 2020 to 28 Sep 2026